MX2007013084A - Pirrolopiridinas sustituidas, composiciones que las contienen, proceso de fabricacion y utilizacion. - Google Patents

Pirrolopiridinas sustituidas, composiciones que las contienen, proceso de fabricacion y utilizacion.

Info

Publication number
MX2007013084A
MX2007013084A MX2007013084A MX2007013084A MX2007013084A MX 2007013084 A MX2007013084 A MX 2007013084A MX 2007013084 A MX2007013084 A MX 2007013084A MX 2007013084 A MX2007013084 A MX 2007013084A MX 2007013084 A MX2007013084 A MX 2007013084A
Authority
MX
Mexico
Prior art keywords
pyridines
producing
composition containing
substituted pyrrolo
pyrrolo
Prior art date
Application number
MX2007013084A
Other languages
English (en)
Inventor
Fabrice Viviani
Michel Tabart
Frank Halley
Catherine Souaille
Pascal Desmazeau
Eric Bacque
Baptiste Ronan
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of MX2007013084A publication Critical patent/MX2007013084A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

Pirrolopiridinas sustituidas, composiciones que las contienen, proceso de fabricacion, y utilizacion. La presente invencion se refiere particularmente a la preparacion de pirrolopiridinas sustituidas, composiciones que las contienen, su proceso de preparacion, y su utilizacion como medicamento, en particular en tanto como agentes anticancerosos.
MX2007013084A 2005-04-26 2006-04-26 Pirrolopiridinas sustituidas, composiciones que las contienen, proceso de fabricacion y utilizacion. MX2007013084A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0504173A FR2884821B1 (fr) 2005-04-26 2005-04-26 Pyrrolopyridines substitues, compositions les contenant, procede de fabrication et utilisation
PCT/FR2006/000925 WO2006114520A2 (fr) 2005-04-26 2006-04-26 Pyrrolopyridines substitues, compositions les contenant, procede de fabrication et utilisation

Publications (1)

Publication Number Publication Date
MX2007013084A true MX2007013084A (es) 2008-01-11

Family

ID=35517344

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2007013084A MX2007013084A (es) 2005-04-26 2006-04-26 Pirrolopiridinas sustituidas, composiciones que las contienen, proceso de fabricacion y utilizacion.

Country Status (33)

Country Link
US (1) US7947706B2 (es)
EP (1) EP1877409B1 (es)
JP (1) JP2008539211A (es)
KR (1) KR20080007229A (es)
CN (1) CN101166739A (es)
AR (1) AR061386A1 (es)
AT (1) ATE433976T1 (es)
AU (1) AU2006239105A1 (es)
BR (1) BRPI0613161A2 (es)
CA (1) CA2605744A1 (es)
CR (1) CR9463A (es)
CY (1) CY1109369T1 (es)
DE (1) DE602006007337D1 (es)
DK (1) DK1877409T3 (es)
DO (1) DOP2006000096A (es)
EA (1) EA012983B1 (es)
ES (1) ES2328629T3 (es)
FR (1) FR2884821B1 (es)
GT (1) GT200600174A (es)
HR (1) HRP20090494T1 (es)
IL (1) IL186523A0 (es)
MA (1) MA29480B1 (es)
MX (1) MX2007013084A (es)
NO (1) NO20075918L (es)
PA (1) PA8671301A1 (es)
PE (1) PE20071420A1 (es)
PL (1) PL1877409T3 (es)
PT (1) PT1877409E (es)
RS (1) RS51136B (es)
SI (1) SI1877409T1 (es)
TN (1) TNSN07360A1 (es)
TW (1) TW200718701A (es)
WO (1) WO2006114520A2 (es)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8119655B2 (en) 2005-10-07 2012-02-21 Takeda Pharmaceutical Company Limited Kinase inhibitors
EP2223925A1 (en) * 2006-10-09 2010-09-01 Takeda Pharmaceutical Company Limited Kinase inhibitors
JP2010505962A (ja) * 2006-10-09 2010-02-25 武田薬品工業株式会社 キナーゼ阻害剤
WO2008063888A2 (en) 2006-11-22 2008-05-29 Plexxikon, Inc. Compounds modulating c-fms and/or c-kit activity and uses therefor
JP5442449B2 (ja) 2006-12-22 2014-03-12 アステックス、セラピューティックス、リミテッド 新規化合物
US8895745B2 (en) * 2006-12-22 2014-11-25 Astex Therapeutics Limited Bicyclic heterocyclic compounds as FGFR inhibitors
US20100190777A1 (en) 2007-07-17 2010-07-29 Plexxikon Inc. Compounds and methods for kinase modulation, and indications therefor
GB0720038D0 (en) 2007-10-12 2007-11-21 Astex Therapeutics Ltd New compounds
GB0720041D0 (en) 2007-10-12 2007-11-21 Astex Therapeutics Ltd New Compounds
GB0810902D0 (en) 2008-06-13 2008-07-23 Astex Therapeutics Ltd New compounds
DE102008052943A1 (de) 2008-10-23 2010-04-29 Merck Patent Gmbh Azaindolderivate
CR20170089A (es) 2009-04-03 2017-07-17 Plexxikon Inc Composiciones del acido propano-1--sulfonico {3-[5-(4-cloro-fenil)-1h-pirrolo [2,3-b] piridina-3-carbonil] -2,4-difluoro-fenil}-amida y el uso de las mismas
GB0906470D0 (en) 2009-04-15 2009-05-20 Astex Therapeutics Ltd New compounds
GB0906472D0 (en) 2009-04-15 2009-05-20 Astex Therapeutics Ltd New compounds
US20110030037A1 (en) * 2009-07-07 2011-02-03 Vadim Olshansky Zone migration in network access
US8329724B2 (en) 2009-08-03 2012-12-11 Hoffmann-La Roche Inc. Process for the manufacture of pharmaceutically active compounds
NZ599866A (en) 2009-11-06 2014-09-26 Plexxikon Inc Compounds and methods for kinase modulation, and indications therefor
MA34948B1 (fr) 2011-02-07 2014-03-01 Plexxikon Inc Composes et procedes de modulation de kinase, et leurs indications
TWI558702B (zh) 2011-02-21 2016-11-21 普雷辛肯公司 醫藥活性物質的固態形式
US20150336948A1 (en) * 2012-05-29 2015-11-26 Merck Sharp & Dohme Corp. Isotopically Labeled Biaryl Urea Compounds
US9150570B2 (en) 2012-05-31 2015-10-06 Plexxikon Inc. Synthesis of heterocyclic compounds
US20140275082A1 (en) * 2013-03-14 2014-09-18 Abbvie Inc. Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
GB201310464D0 (en) * 2013-06-12 2013-07-24 Lytix Biopharma As Compounds
GB201310460D0 (en) * 2013-06-12 2013-07-24 Lytix Biopharma As Compounds

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3254843B2 (ja) * 1993-08-09 2002-02-12 三菱ウェルファーマ株式会社 新規縮合ヘテロ環誘導体
US6335342B1 (en) * 2000-06-19 2002-01-01 Pharmacia & Upjohn S.P.A. Azaindole derivatives, process for their preparation, and their use as antitumor agents
GB0115109D0 (en) * 2001-06-21 2001-08-15 Aventis Pharma Ltd Chemical compounds
JP2005508904A (ja) * 2001-09-11 2005-04-07 スミスクライン ビーチャム コーポレーション 血管新生阻害剤としてのフロ−及びチエノピリミジン誘導体
WO2003028724A1 (en) * 2001-10-04 2003-04-10 Smithkline Beecham Corporation Chk1 kinase inhibitors
WO2003035621A1 (en) * 2001-10-22 2003-05-01 The Research Foundation Of State University Of New York Protein kinase and phosphatase inhibitors, methods for designing them, and methods of using them
WO2003082868A1 (en) * 2002-03-28 2003-10-09 Eisai Co., Ltd. 7-azaindoles as inhibitors of c-jun n-terminal kinases for the treatment of neurodegenerative disorders
FR2878849B1 (fr) * 2004-12-06 2008-09-12 Aventis Pharma Sa Indoles substitues, compositions les contenant, procede de fabrication et utilisation

Also Published As

Publication number Publication date
JP2008539211A (ja) 2008-11-13
PT1877409E (pt) 2009-09-16
SI1877409T1 (sl) 2009-12-31
CY1109369T1 (el) 2014-07-02
RS51136B (sr) 2010-10-31
FR2884821A1 (fr) 2006-10-27
WO2006114520A2 (fr) 2006-11-02
PA8671301A1 (es) 2006-12-07
AU2006239105A1 (en) 2006-11-02
BRPI0613161A2 (pt) 2010-12-21
EA200702329A1 (ru) 2008-02-28
DE602006007337D1 (de) 2009-07-30
MA29480B1 (fr) 2008-05-02
EP1877409B1 (fr) 2009-06-17
EA012983B1 (ru) 2010-02-26
TNSN07360A1 (en) 2008-12-31
US20080139606A1 (en) 2008-06-12
NO20075918L (no) 2007-11-19
EP1877409A2 (fr) 2008-01-16
WO2006114520A3 (fr) 2007-03-01
TW200718701A (en) 2007-05-16
KR20080007229A (ko) 2008-01-17
PL1877409T3 (pl) 2009-12-31
HRP20090494T1 (hr) 2009-10-31
DOP2006000096A (es) 2007-04-15
AR061386A1 (es) 2008-08-27
FR2884821B1 (fr) 2007-07-06
CR9463A (es) 2008-02-21
CN101166739A (zh) 2008-04-23
DK1877409T3 (da) 2009-10-05
PE20071420A1 (es) 2007-01-20
US7947706B2 (en) 2011-05-24
ATE433976T1 (de) 2009-07-15
IL186523A0 (en) 2008-01-20
ES2328629T3 (es) 2009-11-16
CA2605744A1 (fr) 2006-11-02
GT200600174A (es) 2006-12-26

Similar Documents

Publication Publication Date Title
TNSN07360A1 (en) Substituted pyrrolo-pyridines, composition containing them, method for their producing and use thereof
MX2007008790A (es) Pirazolo piridinas sustituidas, composiciones que las contienen, metodo de produccion de las mismas, y su uso.
UA94417C2 (ru) Замещенные 7-азаиндазолы, композиция, которая их содержит, и применение
TW200621777A (en) New dihydropteridione derivatives, process for their manufacture and their use as medicament
MX2011011661A (es) Compuestos 1-cianoetilheterociclilcarboxamida sustituidos 750.
TW200621262A (en) New dihydropteridione derivatives, process for their manufacture and their use as medicament
TW200626593A (en) Novel compounds
TW200745084A (en) Novel compounds
PL1891004T3 (pl) Pentafluorosulfanylo-podstawiony związek i jego zastosowanie do wytwarzania środków leczniczych
TW200745003A (en) Novel compounds
TW200640857A (en) Substituted pyrroles and imidazoles, compositions containing same, manufacturing process therefor and use thereof
TW200630336A (en) Novel compounds
TW200621690A (en) Novel compounds
TW200738659A (en) Novel compounds
TW200634007A (en) Substituted indoles, compositions containing them, production process and use
TW200726758A (en) New pyridine analogues
UA98804C2 (ru) Катехоламиновые производные и фармацевтическая композиция на их основе
TW200745122A (en) New compounds I
TW200714598A (en) Urea derivatives, methods for their manufacture, and uses therefor
TNSN08321A1 (en) Dimers of artemisinin derivatives, preparation thereof and therapeutic use thereof
TW200738627A (en) Trialkylsilyl-indoles
MX2007006042A (es) Bengamidas que poseen un ciclo caprolactama sustituido, procedimiento de preparacion, composiciones que las contienen y utilizacion.
MX2009000768A (es) Lactamas macrociclicas.
GEP20084470B (en) New phenylpyridinylpiperazine compounds, a process for their preparation and pharmaceutical compositions containing them
TW200613315A (en) Estradiol prodrugs

Legal Events

Date Code Title Description
FG Grant or registration